Last updated: 14 June 2024 at 5:01pm EST

Margaret McGlynn Net Worth




The estimated Net Worth of Margaret G Mcglynn is at least $5.52 Milione dollars as of 12 June 2024. Ms. Mcglynn owns over 6,670 units of Vertex Pharmaceuticals stock worth over $4,970,528 and over the last 20 years she sold VRTX stock worth over $0. In addition, she makes $545,006 as Independent Director at Vertex Pharmaceuticals.

Ms. McGlynn VRTX stock SEC Form 4 insiders trading

Margaret has made over 23 trades of the Vertex Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently she exercised 6,670 units of VRTX stock worth $3,166,516 on 12 June 2024.

The largest trade she's ever made was exercising 20,000 units of Vertex Pharmaceuticals stock on 9 January 2020 worth over $66,400. On average, Margaret trades about 1,725 units every 30 days since 2005. As of 12 June 2024 she still owns at least 10,470 units of Vertex Pharmaceuticals stock.

You can see the complete history of Ms. Mcglynn stock trades at the bottom of the page.





Margaret McGlynn biography

Margaret G. McGlynn is Independent Director of Vertex Pharmaceuticals Incorporated. Ms. McGlynn retired from Merck & Co. in 2009, where she served as President, Vaccines and Infectious Diseases and as President, Hospital and Specialty Products. During her 26 year career at Merck, she also held various leadership roles in the U.S. and globally in marketing, sales, managed care and business development. Following her retirement, Ms. McGlynn served as the President and Chief Executive Officer of the International AIDS Vaccine Initiative, a global not-for-profit organization whose mission is to ensure the development of safe, effective and accessible HIV vaccines for use throughout the world, from 2011 until 2015. Ms. McGlynn serves as a member of the Board of Directors for Air Products and Chemicals, Inc., a company specializing in gases and chemicals for industrial uses, and Amicus Therapeutics, Inc., a biopharmaceutical company. She is also a member of the National Industrial Advisory Committee at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. Ms. McGlynn holds a B.S. in Pharmacy and an M.B.A. in Marketing from the State University of New York at Buffalo.

What is the salary of Margaret McGlynn?

As the Independent Director of Vertex Pharmaceuticals, the total compensation of Margaret McGlynn at Vertex Pharmaceuticals is $545,006. There are 14 executives at Vertex Pharmaceuticals getting paid more, with Jeffrey Leiden having the highest compensation of $18,790,000.



How old is Margaret McGlynn?

Margaret McGlynn is 60, she's been the Independent Director of Vertex Pharmaceuticals since 2011. There are 5 older and 19 younger executives at Vertex Pharmaceuticals. The oldest executive at Vertex Pharmaceuticals, Inc. is William Young, 75, who is the Independent Director.

What's Margaret McGlynn's mailing address?

Margaret's mailing address filed with the SEC is 700 QUINCE ORCHARD ROAD, , GAITHERSBURG, , 20878.

Insiders trading at Vertex Pharmaceuticals

Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden e Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.



What does Vertex Pharmaceuticals do?

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.



What does Vertex Pharmaceuticals's logo look like?

Vertex Pharmaceuticals, Inc. logo

Complete history of Ms. Mcglynn stock trades at Amicus Therapeutics Inc, Novavax, Vertex Pharmaceuticals e Air Products & Chemicals

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
12 Jun 2024 Margaret G Mcglynn
Opzione 6,670 $15.86 $105,786
12 Jun 2024
10,470
10 Jun 2023 Margaret G Mcglynn
Opzione 3,100 $7.47 $23,157
10 Jun 2023
3,800
17 Jun 2022 Margaret G Mcglynn
Opzione 700 $40.24 $28,168
17 Jun 2022
700
4 Mar 2024 Margaret G Mcglynn
Opzione 15,000 $2.80 $42,000
4 Mar 2024
66,789
13 Jan 2023 Margaret G Mcglynn
Opzione 15,000 $3.32 $49,800
13 Jan 2023
65,705
2 May 2022 Margaret G Mcglynn
Opzione 15,000 $4.79 $71,850
2 May 2022
53,034
3 May 2021 Margaret G Mcglynn
Opzione 10,000 $7.51 $75,100
3 May 2021
37,919
17 Apr 2020 Margaret G Mcglynn
Opzione 10,000 $2.81 $28,100
17 Apr 2020
32,064
9 Jan 2020 Margaret G Mcglynn
Opzione 20,000 $3.32 $66,400
9 Jan 2020
42,064
16 May 2018 Margaret G Mcglynn
Opzione 10,000 $3.32 $33,200
16 May 2018
25,814
10 Nov 2015 Margaret G Mcglynn
Acquistare 10,000 $10.27 $102,700
10 Nov 2015
10,000
8 Apr 2022 Margaret G Mcglynn
Direttore
Opzione 5,000 $127.54 $637,700
8 Apr 2022
6,099
31 Mar 2022 Margaret G Mcglynn
Direttore
Opzione 5,000 $127.54 $637,700
31 Mar 2022
6,099
28 Jan 2022 Margaret G Mcglynn
Direttore
Opzione 5,000 $127.54 $637,700
28 Jan 2022
6,099
22 Oct 2019 Margaret G Mcglynn
Direttore
Opzione 20,000 $72.14 $1,442,800
22 Oct 2019
24,124
13 Aug 2019 Margaret G Mcglynn
Direttore
Opzione 10,000 $81.54 $815,400
13 Aug 2019
14,124
2 Mar 2018 Margaret G Mcglynn
Direttore
Opzione 10,000 $81.54 $815,400
2 Mar 2018
16,312
22 Jan 2018 Margaret G Mcglynn
Direttore
Opzione 20,000 $59.55 $1,191,000
22 Jan 2018
16,217
18 Nov 2015 Margaret G Mcglynn
Direttore
Opzione 12,500 $57.27 $715,875
18 Nov 2015
13,588
3 Aug 2015 Margaret G Mcglynn
Direttore
Opzione 12,500 $57.27 $715,875
3 Aug 2015
13,588
1 Jun 2015 Margaret G Mcglynn
Direttore
Opzione 12,500 $55.22 $690,250
1 Jun 2015
13,588
6 Apr 2015 Margaret G Mcglynn
Direttore
Opzione 12,500 $53.85 $673,125
6 Apr 2015
13,588
7 Nov 2012 Margaret G Mcglynn
Direttore
Acquistare 1,000 $45.50 $45,500
7 Nov 2012
1,000


Vertex Pharmaceuticals executives and stock owners

Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: